Prosecution Insights
Last updated: August 18, 2026

Examiner: SASAN, ARADHANA

Tech Center 1600 • Art Units: 1615 1654

This examiner grants 64% of resolved cases

Performance Statistics

64.3%
Allow Rate
+4.3% vs TC avg
1,174
Total Applications
+26.6%
Interview Lift
1149
Avg Prosecution Days
Based on 1112 resolved cases, 2023–2026

Rejection Statute Breakdown

1.6%
§101 Eligibility
12.2%
§102 Novelty
45.9%
§103 Obviousness
17.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18591930 COSMETIC COMPOSITION FOR ACNE CARE Non-Final OA L'OREAL
18093654 ORAL GEL COMPOSITIONS Non-Final OA Colgate-Palmolive Company
18681256 ANTIMICROBIAL COMPOSITIONS Final Rejection Firmenich SA
18687161 ANTIMICROBIAL COMBINATIONS Non-Final OA SYMRISE AG
18573229 PHARMACEUTICAL COMPOSITIONS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR Final Rejection Blueprint Mdeicines Coroporation
18467324 Compositions of Iboga Alkaloids and Methods of Treatment Non-Final OA Soneira Inc., P.B.C.
18000918 HEMP SPROUT PRODUCTS AND METHODS FOR PRODUCING SAME Final Rejection CReDO Science, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month